Session Details

F056 Dermoscopy for the Non-dermoscopist

Sat, Mar 9, 1:00 PM - 3:00 PM
Room 6D
2 CME Available Forum
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

Novice dermoscopists will be taught recognizable dermoscopic patterns to assist in the diagnosis of pigmented lesions. We will discuss a simple pattern recognition system that can be incorporated into routine dermatologic practice. The session will also include dermoscopy of special sites, including the face and acral surfaces. Participants will be shown unknown cases throughout the session for self-assessment and the approach to diagnosis of these cases will be reviewed. By incorporating dermoscopy into everyday practice, participants will be able to improve their diagnostic accuracy in detecting melanoma and other skin cancers.

LEARNING OBJECTIVES

1.

Recognize characteristic dermoscopic structures of benign and malignant lesions.

2.

Use dermoscopy to distinguish benign from suspicious lesions that require biopsy.

3.

Use dermoscopy to distinguish benign from suspicious lesions that require biopsy.

SCHEDULE

9:00 PM

Introduction / Melanocytic Structures and Benign Patterns

Jennifer A. Stein, MD, PhD, FAAD

9:20 PM

Melanoma

Elizabeth Gates Berry, MD, FAAD

9:35 PM

Non-melanocytic Patterns

Michelle B Tarbox, MD, FAAD

9:55 PM

Face

Tracey Liebman, MD, FAAD

10:10 PM

Acral / Mucosal

Jennifer A. Stein, MD, PhD, FAAD

10:25 PM

Cases

Kelly C Nelson, MD, FAAD

10:40 PM

Q+A

SPEAKERS

Elizabeth Gates Berry, MD, FAAD

Elizabeth Gates Berry, MD, FAAD

Tracey Liebman, MD, FAAD

Tracey Liebman, MD, FAAD

Kelly C Nelson, MD, FAAD

Kelly C Nelson, MD, FAAD

Jennifer A. Stein, MD, PhD, FAAD

Jennifer A. Stein, MD, PhD, FAAD

Michelle B Tarbox, MD, FAAD

Michelle B Tarbox, MD, FAAD

HANDOUTS

Login to view handouts

SPEAKER DISCLOSURES

Elizabeth Gates Berry, MD, FAAD

Barco N.V. – Consultant(Fees); Bristol-Myers Squibb – Advisory Board(Fees); Orlucent – Investigator(Grants/Research Funding);

Tracey Liebman, MD, FAAD

No financial relationships exist with ineligible companies.

Kelly C Nelson, MD, FAAD

No financial relationships exist with ineligible companies.

Jennifer A. Stein, MD, PhD, FAAD

UpToDate, Inc – Other(Patent royalties or other compensation for Intellectual Property Rights);

Michelle B Tarbox, MD, FAAD

Castle Biosciences – Investigator(Grants/Research Funding); Novartis – Advisory Board(Honoraria); Sanofi/Regeneron – Investigator(Grants/Research Funding);